Matthew Kunicki

Interro IQ

BIOGRAPHY

Matthew Kunicki is the Founder and CEO of Interro IQ, a research services company building AI-driven flow cytometry for biomarker discovery. His team is developing a novel data layer of the immune response, directly applicable to multi-omic therapeutic and optimal care strategies.

Matthew previously held an associate research role at Stanford University's Department of Stem Cell and Regenerative Medicine, characterizing regulatory T-cell dysfunction in autoimmunity and immune deficiency using mass cytometry. At Pfizer, he supported flow cytometry applications, data management, and analysis across early development and pre-clinical divisions.